Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2022-12-01 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
2022年第五次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2022 fifth extraordinary general meeting of shareholders of Ningbo New Zhi Biotechnology Co., Ltd. It includes information about the meeting date, attendance, voting results on various proposals including amendments to the company charter, authorization for business registration changes, use of idle raised funds, and election of board members and supervisors. It also contains legal opinions confirming the legality and validity of the meeting and resolutions. The document is not a full annual or interim report, nor a financial statement or earnings release. It is not a proxy solicitation or a presentation. It is a formal announcement of voting results and decisions made at a shareholders meeting. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and content support this classification with high confidence.
2022-12-01 Chinese
北京炜衡（宁波）律师事务所关于宁波新芝生物科技股份有限公司2022年第五次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, and voting results of the 2022 fifth extraordinary general meeting (临时股东大会) of Ningbo New Zhisheng Biotechnology Co., Ltd. It details the legality and validity of the meeting's convening, the qualifications of attendees, the voting procedures, and the results of various resolutions including amendments to the company charter and election of board members. The document is not a financial report, earnings release, or management discussion, but a legal opinion on the shareholder meeting and its resolutions. This type of document corresponds to Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholder meeting. The document length is over 7,000 characters and contains detailed voting results, not just an announcement of a report publication or a brief notice. Therefore, the correct classification is DVA with high confidence.
2022-12-01 Chinese
关于调整募集资金投资项目拟投入募集资金金额的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Ningbo New Gene Bio-tech Co., Ltd. regarding the adjustment of the amount of funds raised to be invested in specific projects. It details the fundraising amounts, the adjustment of investment amounts for various projects, and includes opinions from independent directors, the supervisory board, and the sponsoring institution. The document references regulatory approvals and compliance with securities regulations. It is not a full financial report, earnings release, or audit report, but rather an update on the use and allocation of capital raised through a public stock issuance. This fits the definition of a Capital/Financing Update (CAP), as it concerns fundraising activities and capital allocation adjustments. The document length is about 3007 characters, which is sufficient for a detailed announcement but not a full annual or interim report. Therefore, the classification is CAP with high confidence.
2022-12-01 Chinese
董事长、监事会主席、高级管理人员换届公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the change of the company's chairman, supervisory board chairman, and senior management personnel. It details the election and appointment of these individuals, their shareholdings, and confirms their qualifications and compliance with relevant laws and company regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses on management changes and governance compliance. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 4437 characters, which is consistent with a detailed announcement rather than a full report.
2022-12-01 Chinese
第八届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the first meeting of the eighth board of directors of Ningbo New Zhi Biotechnology Co., Ltd. It includes information about the election and reappointment of board members and senior management, meeting attendance, voting results, and compliance with company law and articles of association. There is no financial data or report content such as financial statements or management discussion. The document focuses on board and management changes and appointments. It is not an annual report, audit report, earnings release, or any other financial report. It is not a proxy statement or voting results announcement for shareholders. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 4477 characters, which is sufficient for a detailed board meeting resolution announcement. Confidence is high due to the clear content and context.
2022-12-01 Chinese
第八届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the first meeting of the eighth Supervisory Board of Ningbo New Zhisheng Biotechnology Co., Ltd. It details meeting attendance, election of the Supervisory Board chairman, and adjustments to investment project funding. The document is an official disclosure of board-level decisions and changes in management structure, specifically related to the Supervisory Board. It does not contain financial statements or detailed financial data, nor is it a report or presentation. It is not an announcement of voting results at a shareholder meeting but rather a management/board information announcement. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and focused on board resolutions, consistent with MANG filings.
2022-12-01 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.